Cargando…
Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tehran University of Medical Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426761/ https://www.ncbi.nlm.nih.gov/pubmed/34568200 http://dx.doi.org/10.18502/ijph.v50i7.6654 |
| _version_ | 1783750098192171008 |
|---|---|
| author | Moghadasi, Abdorreza Naser |
| author_facet | Moghadasi, Abdorreza Naser |
| author_sort | Moghadasi, Abdorreza Naser |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8426761 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Tehran University of Medical Sciences |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84267612021-09-24 Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients Moghadasi, Abdorreza Naser Iran J Public Health Letter to the Editor Tehran University of Medical Sciences 2021-07 /pmc/articles/PMC8426761/ /pubmed/34568200 http://dx.doi.org/10.18502/ijph.v50i7.6654 Text en Copyright © 2021 Moghadasi. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Moghadasi, Abdorreza Naser Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title | Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title_full | Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title_fullStr | Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title_full_unstemmed | Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title_short | Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients |
| title_sort | lack of attention to the administration of fampridine as a symptomatic drug in iranian multiple sclerosis patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426761/ https://www.ncbi.nlm.nih.gov/pubmed/34568200 http://dx.doi.org/10.18502/ijph.v50i7.6654 |
| work_keys_str_mv | AT moghadasiabdorrezanaser lackofattentiontotheadministrationoffampridineasasymptomaticdruginiranianmultiplesclerosispatients |